Growler obviously you don’t get the point which is Diamond shouldn’t make statements as “no dilution” “we have inbound third parties interested and we expand this interest” also a video then later pulled out “ Prof Voits will be ANP PI in Europe trial” then in same video first talk down Sarepta because failure on gene therapy then few week later makes his appreciation of Sarepta website.
I don’t know about you but IMO all the above are purely misleading and not professional from a m.d
$15m cap raise Fresh Equities at 24c, page-132
-
- There are more pages in this discussion • 724 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 250808 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 312804 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |